Haiyan Xu
Shenyang Pharmaceutical University(CN)Fujian Medical University(CN)Dalian University of Technology(CN)Metallurgical Corporation of China (China)(CN)Tianjin Medical University Cancer Institute and Hospital(CN)Wuhan University(CN)Dalian University(CN)First Affiliated Hospital of Guangzhou Medical University(CN)Anyang Eye Hospital(CN)Zhongnan Hospital of Wuhan University(CN)Fu Wai Hospital(CN)Guangzhou Medical University(CN)
Publications by Year
Research Areas
Cardiac Valve Diseases and Treatments, RNA modifications and cancer, Cancer-related molecular mechanisms research, Cardiovascular Function and Risk Factors, Pharmacogenetics and Drug Metabolism
Most-Cited Works
- → Black Cohosh (Cimicifuga racemosaL.) Protects against Menadione-Induced DNA Damage through Scavenging of Reactive Oxygen Species: Bioassay-Directed Isolation and Characterization of Active Principles(2002)92 cited
- → Disposition of Naringenin via Glucuronidation Pathway Is Affected by Compensating Efflux Transporters of Hydrophilic Glucuronides(2009)91 cited
- LncRNA Sox2ot overexpression serves as a poor prognostic biomarker in gastric cancer.(2016)
- → Plasma homocysteine thiolactone adducts associated with risk of coronary heart disease(2005)65 cited
- → Prognostic Value of N-Terminal Pro–B-Type Natriuretic Peptide in Elderly Patients With Valvular Heart Disease(2020)58 cited
- → Determination of non-liposomal and liposomal doxorubicin in plasma by LC–MS/MS coupled with an effective solid phase extraction: In comparison with ultrafiltration technique and application to a pharmacokinetic study(2017)55 cited